Transaction Details:

Hash cfbf3db3c8aefc1076ab409b9bb07fb3b1d23ccc3a062a20b4b32362e1e20712
Blockhash 1ea21a14878348b471a161c107dc4f888b5fd966e867e8b5e2f14401a0252879
Blocktime 2020-02-03 22:42
Confirmations 135353

Inputs

Index Previous Output Address
0 dc99a35d32b3862f37ae7d64d1dc77856a51449952af135c22627402a8198768:1 b'2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'

Outputs

Index Redeemed in Address Amount
0 Not yet redeemed N/A 0 CBL
1 a09b787a2dfa42794f9078b83feda261da2aeee249dd34da997d407ff84e8eb8 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd 99.99969606 CBL
{
"txid": cfbf3db3c8aefc1076ab409b9bb07fb3b1d23ccc3a062a20b4b32362e1e20712,
"time": 1580769735,
"blocktime": 1580769735,
"blockhash": 1ea21a14878348b471a161c107dc4f888b5fd966e867e8b5e2f14401a0252879,
"confirmations": 135353,
"vin ": [
{
"txid": dc99a35d32b3862f37ae7d64d1dc77856a51449952af135c22627402a8198768
"vout": 1
"scriptSig": {'asm': '30450221009e3945ec30ae177beb0d89202d82605df30afbfc275aec0097749db705fc4d3c022071104929bb4f57026e17d09bb9636d8d0a5eb431113ecbf6b6b42c264b4366fd01 03f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38', 'hex': '4830450221009e3945ec30ae177beb0d89202d82605df30afbfc275aec0097749db705fc4d3c022071104929bb4f57026e17d09bb9636d8d0a5eb431113ecbf6b6b42c264b4366fd012103f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38'}
"sequence": 4294967295
}
],
"vout ": [
{
"value": 0
"n": 0
"scriptPubKey": {
"asm": 73706b65164ff70a0a0153ccf31bbaf3f020c19d OP_DROP 73706b6b434339624a536b7571415a5846 OP_DROP 73706b6b43544144334b73734c42373966 OP_DROP 73706b6b43443855617a546f32594a6b43 OP_DROP 73706b6b4352474179396f336154363944 OP_DROP 73706b6602 OP_DROP OP_RETURN 7b69057469746c6553694c7a776569746c696e69656e7468657261706965206265696d2070726f73746174616b61727a696e6f6d20636162617a69746178656c207562657277696e64657420726573697374656e7a656e6907746f70686173685369403562643732633963353766633133333435663234636130616134393864356431313162326461666432313239393362383865303034666632346265363930633869046d6574615b7b6906736368656d6153690a736368656d612e6f726769096d65646961747970655369136170706c69636174696f6e2f6c642b6a736f6e6904646174617b690840636f6e74657874536912687474703a2f2f736368656d612e6f72672f690540747970655369105363686f6c61726c7941727469636c656908656e636f64696e675b7b245323690369054074797065690b4d656469614f626a656374690a636f6e74656e7455726c693e68747470733a2f2f6c696e6b2e737072696e6765722e636f6d2f636f6e74656e742f7064662f31302e31303037253246424630333337303032302e706466690e656e636f64696e67466f726d6174690f6170706c69636174696f6e2f7064665d690567656e726553690f6a6f75726e616c2d61727469636c65690a6964656e7469666965725b247b236902245323690369054074797065690d50726f706572747956616c7565690a70726f706572747949446903444f49690576616c7565691231302e313030372f62663033333730303230245323690369054074797065690d50726f706572747956616c7565690a70726f70657274794944690449534343690576616c75656937434339624a536b7571415a58462d43544144334b73734c423739662d43443855617a546f32594a6b432d4352474179396f33615436394469046e616d6553694e5a776569746c696e69656e7468657261706965206265696d2050726f73746174616b61727a696e6f6d3a20436162617a69746178656c20c3bc62657277696e64657420526573697374656e7a656e69097075626c69736865727b6905407479706553690c4f7267616e697a6174696f6e69046e616d6553690f537072696e676572204e61747572657d690d646174655075626c697368656453690a323031312d30392d30317d7d5d7d
"hex": 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
"type": nulldata
},
"items": [
{'type': 'stream', 'name': 'iscc', 'createtxid': '9dc120f0f3ba1bf3cc53010a0af74f164961f37595bdd9a89b5064e60304c070', 'streamref': '22580-300-49565', 'publishers': ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'], 'keys': ['CC9bJSkuqAZXF', 'CTAD3KssLB79f', 'CD8UazTo2YJkC', 'CRGAy9o3aT69D'], 'offchain': False, 'data': {'json': {'title': 'zweitlinientherapie beim prostatakarzinom cabazitaxel uberwindet resistenzen', 'tophash': '5bd72c9c57fc13345f24ca0aa498d5d111b2dafd212993b88e004ff24be690c8', 'meta': [{'schema': 'schema.org', 'mediatype': 'application/ld+json', 'data': {'@context': 'http://schema.org/', '@type': 'ScholarlyArticle', 'encoding': [{'@type': 'MediaObject', 'contentUrl': 'https://link.springer.com/content/pdf/10.1007%2FBF03370020.pdf', 'encodingFormat': 'application/pdf'}], 'genre': 'journal-article', 'identifier': [{'@type': 'PropertyValue', 'propertyID': 'DOI', 'value': '10.1007/bf03370020'}, {'@type': 'PropertyValue', 'propertyID': 'ISCC', 'value': 'CC9bJSkuqAZXF-CTAD3KssLB79f-CD8UazTo2YJkC-CRGAy9o3aT69D'}], 'name': 'Zweitlinientherapie beim Prostatakarzinom: Cabazitaxel ├╝berwindet Resistenzen', 'publisher': {'@type': 'Organization', 'name': 'Springer Nature'}, 'datePublished': '2011-09-01'}}]}}}
]
},
{
"value": 99.99969606
"n": 1
"scriptPubKey": {
"asm": OP_DUP OP_HASH160 70f3924b82ad8ba9ca4b38ee85a83bd99c142f9f OP_EQUALVERIFY OP_CHECKSIG
"hex": 76a91470f3924b82ad8ba9ca4b38ee85a83bd99c142f9f88ac
"reqSigs": 1
"type": pubkeyhash
"addresses": ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd']
}
}
]
}